Viewing Study NCT00891735


Ignite Creation Date: 2025-12-24 @ 10:21 PM
Ignite Modification Date: 2025-12-25 @ 7:54 PM
Study NCT ID: NCT00891735
Status: COMPLETED
Last Update Posted: 2013-01-18
First Post: 2009-04-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)
Sponsor: Genentech, Inc.
Organization: